Rights and permissions
About this article
Cite this article
Who should the US pharmacoeconomics ‘watchdog’ be?. Pharmacoecon. Outcomes News 170, 2 (1998). https://doi.org/10.1007/BF03277629
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277629